Primary information |
---|
ID | antitb_1860, |
Name | 27862650 |
N-Terminal modification | Anoplin |
C-Terminal Modification | GLLKRIKTLL |
Chemical Modification | Free |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Origin | Cationic |
Species | Natural |
Strain | Derived from the venom sac of the solitary wasp, Anoplius samariensis |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis mc2 155 |
Cell Line | MIC = 200 μg/mL |
Inhibition Concentration | In vitro |
Sequence | 2016 |
Cytotoxicity | RBC |
In vivo Model | NA |
Lethal Dose | Non toxic to erythrocytes |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | Antifungal (C. parapsilosis) and Antibacterial (Escherichia coli DH5a, Pseudomonas aeruginosa PAO, and Zymomonas mobilis ATCC 10988; Gram-positive bacteria: Bacillus subtilis DELTA) |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1861, |
Name | 27862650 |
N-Terminal modification | Anoplin |
C-Terminal Modification | GLLKRIKTLL |
Chemical Modification | Addition of octanoic acid (C8H16O2) |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Origin | Amphipathic |
Species | Synthetic |
Strain | Anlogue of Anoplin |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis mc2 156 |
Cell Line | MIC = 200 μg/mL |
Inhibition Concentration | In vitro |
Sequence | 2016 |
Cytotoxicity | RBC |
In vivo Model | NA |
Lethal Dose | Non toxic to erythrocytes |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | Antifungal (C. parapsilosis) and Antibacterial (Escherichia coli DH5a, Pseudomonas aeruginosa PAO, and Zymomonas mobilis ATCC 10988; Gram-positive bacteria: Bacillus subtilis DELTA) |
Tertiary Structure (Technique) | Not Predicted), |
Primary information |
---|
ID | antitb_1862, |
Name | 27862650 |
N-Terminal modification | Anoplin |
C-Terminal Modification | GLLKRIKTLL |
Chemical Modification | Addition of decanoic acid (C10H20O2) |
Linear/Cyclic | Amidation |
Length | None |
Chirality | Linear |
Nature | 10 |
Source | L |
Origin | Amphipathic |
Species | Synthetic |
Strain | Anlogue of Anoplin |
Inhibition Concentration | Mycobacterium smegmatis |
In Vitro/ In vivo | Mycobacterium smegmatis mc2 157 |
Cell Line | MIC = 200 μg/mL |
Inhibition Concentration | In vitro |
Sequence | 2016 |
Cytotoxicity | RBC |
In vivo Model | NA |
Lethal Dose | Non toxic to erythrocytes |
Immune Responce | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other activities | NA |
PMID | NA |
Year of Publication | Antifungal (C. parapsilosis) and Antibacterial (Escherichia coli DH5a, Pseudomonas aeruginosa PAO, and Zymomonas mobilis ATCC 10988; Gram-positive bacteria: Bacillus subtilis DELTA) |
Tertiary Structure (Technique) | Not Predicted), |